Ethics Statement
The authors confirm that the ethical policies of the journal, as noted
on the journal’s author guidelines page, have been adhered to. No
ethical approval was required as this is a review article with no
original research data.
Barnard, D. L., Hubbard, V. D., Burton, J., Smee, D. F., Morrey, J. D.,
Otto, M. J., & Sidwell, R. W. (2004). Inhibition of severe acute
respiratory syndrome-associated coronavirus (SARSCoV) by calpain
inhibitors and beta-D-N4-hydroxycytidine. Antivir Chem Chemother,
15 (1), 15-22. doi:10.1177/095632020401500102
Chen, L., Gui, C., Luo, X., Yang, Q., Gunther, S., Scandella, E., . . .
Jiang, H. (2005). Cinanserin is an inhibitor of the 3C-like proteinase
of severe acute respiratory syndrome coronavirus and strongly reduces
virus replication in vitro. J Virol, 79 (11), 7095-7103.
doi:10.1128/jvi.79.11.7095-7103.2005
Chou, K. C., Wei, D. Q., & Zhong, W. Z. (2003). Binding mechanism of
coronavirus main proteinase with ligands and its implication to drug
design against SARS. Biochem Biophys Res Commun, 308 (1), 148-151.
doi:10.1016/s0006-291x(03)01342-1
De Clercq, E. (2006). Potential antivirals and antiviral strategies
against SARS coronavirus infections. Expert Rev Anti Infect Ther,
4 (2), 291-302. doi:10.1586/14787210.4.2.291
Gan, Y. R., Huang, H., Huang, Y. D., Rao, C. M., Zhao, Y., Liu, J. S., .
. . Wei, D. Q. (2006). Synthesis and activity of an octapeptide
inhibitor designed for SARS coronavirus main proteinase. Peptides,
27 (4), 622-625. doi:10.1016/j.peptides.2005.09.006
Gayvert, K. M., Madhukar, N. S., & Elemento, O. (2016). A Data-Driven
Approach to Predicting Successes and Failures of Clinical Trials.Cell Chem Biol, 23 (10), 1294-1301.
doi:10.1016/j.chembiol.2016.07.023
Huang, J. D., Zheng, B. J., & Sun, H. Z. (2008). Helicases as antiviral
drug targets. Hong Kong Med J, 14 Suppl 4 , 36-38.
Kumar, V., Jung, Y. S., & Liang, P. H. (2013). Anti-SARS coronavirus
agents: a patent review (2008 - present). Expert Opin Ther Pat,
23 (10), 1337-1348. doi:10.1517/13543776.2013.823159
Li, G., & De Clercq, E. (2020). Therapeutic options for the 2019 novel
coronavirus (2019-nCoV). In Nat Rev Drug Discov (Vol. 19, pp.
149-150). England.
Lin, C. W., Tsai, F. J., Tsai, C. H., Lai, C. C., Wan, L., Ho, T. Y., .
. . Chao, P. D. (2005). Anti-SARS coronavirus 3C-like protease effects
of Isatis indigotica root and plant-derived phenolic compounds.Antiviral Res, 68 (1), 36-42. doi:10.1016/j.antiviral.2005.07.002
Savarino, A. (2005). Expanding the frontiers of existing antiviral
drugs: possible effects of HIV-1 protease inhibitors against SARS and
avian influenza. J Clin Virol, 34 (3), 170-178.
doi:10.1016/j.jcv.2005.03.005
Sheahan, T. P., Sims, A. C., Zhou, S., Graham, R. L., Pruijssers, A. J.,
Agostini, M. L., . . . Baric, R. S. (2020). An orally bioavailable
broad-spectrum antiviral inhibits SARS-CoV-2 in human airway epithelial
cell cultures and multiple coronaviruses in mice. Sci Transl Med .
doi:10.1126/scitranslmed.abb5883
Shie, J. J., Fang, J. M., Kuo, T. H., Kuo, C. J., Liang, P. H., Huang,
H. J., . . . Wong, C. H. (2005). Inhibition of the severe acute
respiratory syndrome 3CL protease by peptidomimetic
alpha,beta-unsaturated esters. Bioorg Med Chem, 13 (17),
5240-5252. doi:10.1016/j.bmc.2005.05.065
Spinelli, A., & Pellino, G. (2020). COVID-19 pandemic: perspectives on
an unfolding crisis. Br J Surg . doi:10.1002/bjs.11627
Tanner, J. A., Zheng, B. J., Zhou, J., Watt, R. M., Jiang, J. Q., Wong,
K. L., . . . Huang, J. D. (2005). The adamantane-derived bananins are
potent inhibitors of the helicase activities and replication of SARS
coronavirus. Chem Biol, 12 (3), 303-311.
doi:10.1016/j.chembiol.2005.01.006
Wang, Z., Huang, J. D., Wong, K. L., Wang, P. G., Zhang, H. J., Tanner,
J. A., . . . Niccolai, N. (2011). On the mechanisms of bananin activity
against severe acute respiratory syndrome coronavirus. Febs j,
278 (2), 383-389. doi:10.1111/j.1742-4658.2010.07961.x
Yamamoto, M., Matsuyama, S., Li, X., Takeda, M., Kawaguchi, Y., Inoue,
J. I., & Matsuda, Z. (2016). Identification of Nafamostat as a Potent
Inhibitor of Middle East Respiratory Syndrome Coronavirus S
Protein-Mediated Membrane Fusion Using the Split-Protein-Based Cell-Cell
Fusion Assay. Antimicrob Agents Chemother, 60 (11), 6532-6539.
doi:10.1128/aac.01043-16
Zhu, N., Zhang, D., Wang, W., Li, X., Yang, B., Song, J., . . . Tan, W.
(2020). A Novel Coronavirus from Patients with Pneumonia in China, 2019.N Engl J Med, 382 (8), 727-733. doi:10.1056/NEJMoa2001017